Drug intelligence / Profile preview

(5Z)-7-Oxozeanol

Development stage
Unknown
Lead developer
Pfizer
Modality
Small Molecules
Administration
Oral, Intravenous, Intraperitoneal, Intrathecal, Topical
01

Overview

(5Z)-7-Oxozeanol (also known as 5Z-7-oxozeaenol) is a naturally occurring resorcylic acid lactone fungal metabolite that acts as a potent, selective, and irreversible inhibitor of transforming growth factor-β-activated kinase 1 (TAK1, also known as MAP3K7). It covalently binds to a conserved cysteine residue in the ATP-binding pocket of TAK1. By blocking TAK1, (5Z)-7-Oxozeanol prevents the downstream activation of NF-κB and MAPK (p38, JNK, ERK) signaling pathways, which are critical mediators of inflammatory responses and cell survival. It is widely used as a chemical biology tool and research reagent to study inflammatory cascades, autoimmune diseases, and cancer progression, particularly in sensitizing cancer cells to chemotherapy-induced apoptosis.

Other names
(5Z)-7-Oxozeaenol5Z-7-Oxozeaenol5Z-7-OxozeanolLL Z1640-2LL-Z 1640-2LL-Z1640-2LL-Z-1640-2
02

Targets

MEK1 (Dual specificity mitogen-activated protein kinase kinase 1)MAP3K1 (MEKK1)MAP2K7 (Dual specificity mitogen-activated protein kinase kinase 7)MAPK3 (Mitogen-activated protein kinase 1)MAP2K6 (MEK6)TAK1 (Transforming growth factor beta–activated kinase 1)

Beyond the preview

Go deeper on (5Z)-7-Oxozeanol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on (5Z)-7-Oxozeanol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call